Who is sponsoring NCT07494669?

NCT07494669 is sponsored by Region Skane.

What drugs are being tested in NCT07494669?

Interventions in NCT07494669: Risk stratification with proteomics and data from wearables and CGMs.

What condition does NCT07494669 study?

NCT07494669 studies Observation, Postoperative.

Is NCT07494669 still recruiting?

NCT07494669 is currently not yet recruiting. Last updated 27 March 2026.

Last reviewed 2026-03-27 · How we verify

NCT07494669: ProComp

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Proteomics and Physiological Parameters Predicting Complications After Colorectal Cancer Surgery

Not yet recruiting Last updated 27 March 2026

What this trial tests

trial testing Risk stratification with proteomics and data from wearables and CGMs in Observation in 210 participants. Not yet recruiting.

Timeline

7 April 2026

Primary endpoint
30 March 2028

30 March 2028

Quick facts

Lead sponsor	Region Skane
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	210
Start date	7 April 2026
Primary completion	30 March 2028
Estimated completion	30 March 2028

Drugs / interventions tested

Risk stratification with proteomics and data from wearables and CGMs

Conditions studied

Observation — all drugs for Observation →
Postoperative — all drugs for Postoperative →

Sponsor

Region Skane — full company profile →

Who can join

18 and older, any sex, with Observation or Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study combines physiological data from wearables, continuous glucose montiors and proteomics to better assess risk of complications after colorectal surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Region Skane trials

Trials by the same sponsor.

NCT07511673 — The Study is a Randomised Clinical Trial (RCT) to Test if Preoperative Dental Screening is Superior to no Preoperative D · NA · not yet recruiting
NCT07169747 — Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young · Phase 2 · recruiting
NCT07462351 — System-integrated Point-of-Care Ultrasound in Breast Cancer Screening · NA · recruiting
NCT06975696 — Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke · NA · recruiting
NCT07372235 — SSRD and Overweight · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07494669 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Region Skane
Last refreshed: 27 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07494669.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing